CHARLES RIVER LABORATORIES INTERNATIONAL, INC.·4

May 16, 4:29 PM ET

MASSARO GEORGE 4

4 · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Filed May 16, 2025

Insider Transaction Report

Form 4
Period: 2025-05-15
Transactions
  • Sale

    Common Stock

    2025-05-15$136.32/sh35$4,7715,680 total
  • Sale

    Common Stock

    2025-05-15$137.68/sh81$11,1525,599 total
  • Sale

    Common Stock

    2025-05-15$139.05/sh24$3,3375,575 total
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $136.07 to $136.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
  • [F2]This transaction was executed in multiple trades at prices ranging from $137.19 to $138.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
  • [F3]This transaction was executed in multiple trades at prices ranging from $139.02 to $139.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT